blue4u
QMengColdJoke
:
Previously, HBV clinical data were good. They were all 60-70, so antibodies weren't on the market yet. However, COVID-19 antibodies can still fall if they are effective, and the market is clearly underestimated
QMengColdJoke
blue4u
:
This is so ridiculous . It's time to catch up with agencies frantically shorting small herbal medicines. I made a mistake along the way. So I can only continue to carry it hard
102355763 : Bullish only if the new variant is even more contagious than Omicron n more deadly than any of the earlier strains![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
QMengColdJoke : vir is too cheap now, shrunk. Unfortunately, I've already bought it all (this requires controlling positions).
blue4u QMengColdJoke : Previously, HBV clinical data were good. They were all 60-70, so antibodies weren't on the market yet. However, COVID-19 antibodies can still fall if they are effective, and the market is clearly underestimated
QMengColdJoke blue4u : This is so ridiculous
. It's time to catch up with agencies frantically shorting small herbal medicines. I made a mistake along the way. So I can only continue to carry it hard
blue4u QMengColdJoke : US stocks generally fell today, the epidemic was serious, only vaccine stocks rose